Generic

DESONIDE 0.05% CREAM

DESONIDE 0.05% CREAM, a generic topical corticosteroid, has an acquisition cost of $0.43 while hospitals typically charge 10-50 times more than this baseline price.

By David Park , Healthcare Cost Researcher · Published March 15, 2026 · Updated April 3, 2026

Data from CMS files published FY 2024 CMS IPPS. Refreshed weekly.

About the analyst

David Park researches procedure pricing and insurance reimbursement patterns at BillRazor Research. He specializes in cost comparison across care settings and metropolitan areas. Expertise: procedure pricing, insurance reimbursement, cost comparison.

NADAC acquisition cost data

CMS drug pricing benchmarks

Updated 2026-04-03

Drug acquisition cost — DESONIDE 0.05% CREAM

Hospital charges for this drug vary — typically 3–8x the acquisition cost. No observed hospital charge data is available for this specific drug.

$0.43

NADAC acquisition cost

OINTMENT

Dosage form

TOPICAL

Route

Desonide 0.05% cream is a topical corticosteroid prescribed for inflammatory skin conditions like eczema and dermatitis. This generic formulation typically has lower dispensing fees compared to brand-name alternatives, affecting pharmacy reimbursement calculations.

Check your bill amount

Enter the charge for DESONIDE 0.05% CREAM from your bill to compare against the NADAC acquisition cost.

No credit card required. Results in 60 seconds.

Compare your bill against the $0 NADAC acquisition cost → Scan your bill

Research suggests 49–80% of hospital bills contain errors. Our system checks every line item against Medicare benchmarks.

Rates shown are from the 2026 Medicare Physician Fee Schedule and CMS IPPS. BillRazor compares your bill against these data sources. See how it works →

Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.

What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.

Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.